Antiretroviral Treatment Switch Among Treatment-Experienced People with HIV
These findings suggest that B/F/TAF has a lower likelihood of treatment switch/add-on for treatment-experienced PWH than other current ART regimens.
Authors
- Benjamin Chastek (ORCID: https://orcid.org/0000-0002-9759-6001)
- Lisa Le (ORCID: https://orcid.org/0000-0002-1311-1039)
- Sunil Majethia
- Cassidy Trom
- Joshua Cohen (ORCID: https://orcid.org/0000-0002-0180-5367)
- Uche Mordi
- Travis Lim
- Mary J. Christoph
Institutions
- Optum (United States) (US)
- Gilead Sciences (United States) (US)
- Oldham Council (GB)
Publication Details
- Journal
- Journal of health economics and outcomes research
- Published
- 2026-02-24
- DOI
- https://doi.org/10.36469/001c.156180
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gilead Sciences